
Vyleesi (Bremelanotide)
VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked…
VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked…
VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked…
VyLibra is estrogen/progestin COCs, indicated for use by women to prevent pregnancy. (1.1) 1.1 Oral Contraceptive VyLibra tablets are indicated for use by females of reproductive…
VyLibra is estrogen/progestin COCs, indicated for use by women to prevent pregnancy. (1.1) 1.1 Oral Contraceptive VyLibra tablets are indicated for use by females of reproductive…
VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.